Drug
Oral small-molecule prenylation inhibitor treatment of HepD
Multiple studies
Healthy volunteers equally split by gender
Post menopausal women
Subject Recruitment
Timely recruitment/enrollment for all studies
Study outcome
All primary and secondary objectives met; Sponsor planning to move the drug candidate to next stage
Study completed within the sponsor target timeline
